Serlopitant

Unknown Manufacturer

Serlopitant has been investigated for the treatment of Prurigo Nodularis.

Overview

Serlopitant has been investigated for the treatment of Prurigo Nodularis.

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Use of NK-1 receptor antagonists in pruritus
Applicant: TIGERCAT PHARMA INCPriority: 2014
US
8 publications
Use of NK-1 receptor antagonist serlopitant in pruritus
Applicant: MENLO THERAPEUTICS INCPriority: 2014
US
6 publications
Use of NK-1 receptor antagonist serlopitant in pruritus
Applicant: TIGERCAT PHARMA INCPriority: 2014
CN
USE OF NEUROKININ-1 ANTAGONISTS TO TREAT A VARIETY OF PRURITIC CONDITIONS
Applicant: MENLO THERAPEUTICS INCPriority: 2016
CN